Durham, NCNCT04761120Now EnrollingIRB Ready

Mitral Regurgitation Clinical Trial in Durham, NC

Access cutting-edge mitral regurgitation treatment through this clinical trial at a research site in Durham. Study-provided care at no cost to qualified participants.

Sponsored by Abbott Medical Devices

Quick Self-Assessment

See if you qualify for this Durham location

Preparing your pre-screening questions…

Expert Care in Durham

Access mitral regurgitation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related mitral regurgitation treatment provided free

Apply for This Durham Location

Check if you qualify for this mitral regurgitation clinical trial in Durham, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Durham

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Durham site if eligible
  4. 4Begin participation

About This Mitral Regurgitation Study in Durham

ARB-PMCF is a multicenter, observational study of the safety and performance of Abbott annuloplasty devices used in surgical repair of mitral and tricuspid valve regurgitation. The devices included in this study are the SJM™ Rigid Saddle Ring and SJM Séguin Annuloplasty Ring, indicated for mitral valve repair, and the SJM Tailor™ Annuloplasty Ring and SJM Tailor Annuloplasty Band, indicated for mitral or tricuspid repair. Participants will be enrolled prior to undergoing mitral or tricuspid valve repair surgery including an Abbott annuloplasty implant and will complete annual follow-up visits through five years from implant. The study is being conducted to meet post-market clinical follow-up requirements of the European Union Medical Device Directives.

Sponsor: Abbott Medical Devices

Who Can Participate

Inclusion Criteria

Subject is expected to undergo cardiac surgery in ≤90 days including at least one of the following:
implant of a Rigid Saddle Ring, Séguin Ring or a full Tailor Ring without cut zone removal for MR repair
implant of a full Tailor Ring without cut zone removal for TR repair, or
implant of a Tailor Band or partial Tailor Ring with cut zone removed for primary TR repair.
Subject's cardiac surgery will be performed by a study investigator.
Subject will be ≥18 years old at the time of their annuloplasty implant(s).
Subject provides written informed consent and agrees to comply with all required study visits and procedures.

Exclusion Criteria

Subject is below the age of legal consent in the applicable jurisdiction or otherwise lacks legal authority to provide informed consent.
Subject is unable to read or write or has a mental illness or disability that impairs their ability to provide written informed consent.
Subject is expected to have active endocarditis at the time of their Abbott annuloplasty device implant(s).
Subject cannot be unambiguously assigned to a treatment group due to missing data on repair indication(s) or the model and configuration (cut zone removed or not) of their Abbott annuloplasty implant(s).
Subject is participating in another clinical investigation including any treatment outside the investigative site's usual standard of care.
Subject has anomalous anatomy or medical, surgical, psychiatric or social history or conditions that, in the investigator's opinion, would limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Durham?

Yes, this clinical trial (NCT04761120) has an active research site in Durham, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Mitral Regurgitation Treatment Options in Durham, NC

If you're searching for mitral regurgitation treatment options in Durham, NC, this clinical trial (NCT04761120) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Durham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mitral regurgitation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all mitral regurgitation clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Durham, NC

See all heart attack clinical trials recruiting in Durham — not just this study.

Browse Heart Attack Trials in Durham →

Browse More Trials by Condition

Heart Attack TrialsValvular Heart Disease TrialsRheumatoid Arthritis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Durham?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Durham, NC